• Info
  • Significant Ownership

Significant Ownership of S.H.N. Financial Investments Ltd.

Signature - Title
/s/ Nir Shamir - Nir Shamir, Chief Executive Officer
Location
Herzliya, Israel
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by S.H.N. Financial Investments Ltd..

Notify me when S.H.N. Financial Investments Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of S.H.N. Financial Investments Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SOS SOS Ltd. American Depository Shares, representing Class A Ordinary Shares, par value $0.005 9.99% $5.86M $4.52M 920K +338% S.H.N. Financial Investments Ltd. 31 Jul 2025
JZXN Jiuzi Holdings, Inc. Ordinary Shares, par value $0.00039 per share 8% $1.72M $850K 4M +97.7% S.H.N. Financial Investments Ltd. 14 Nov 2025
TENX Tenax Therapeutics, Inc. Common stock, par value $0.0001 4.99% $999K 179K S.H.N. Financial Investments Ltd. 31 Dec 2024
SMX SMX (Security Matters) Public Ltd Co Ordinary Shares, par value $4.70250014886352 per share 4.37% $105K 70.7K S.H.N. Financial Investments Ltd. 31 Dec 2024
EFSH 1847 Holdings LLC Common Shares 4.19% $132K 1.11M S.H.N. Financial Investments Ltd. 31 Dec 2024
APDN Applied DNA Sciences Inc. Common Stock, par value $0.001 per share 3.4% $622K 156K S.H.N. Financial Investments Ltd. 14 Nov 2025
NDRA ENDRA Life Sciences Inc. Common Stock, par value $0.0001 3% 35.6K S.H.N. Financial Investments Ltd. 14 Nov 2025
CHR Cheer Holding, Inc. Class A Ordinary Shares, par value $0.001 per share 2.8% $2.03M $84.2K 2.54M +4.33% S.H.N. Financial Investments Ltd. 14 Nov 2025
CISS C3is Inc. Common Shares, par value $0.01 2.7% $158K 74.2K S.H.N. Financial Investments Ltd. 14 Nov 2025
PSTV Plus Therapeutics, Inc. Common Stock, $0.001 par value 1.51% $735K $142K 1.5M +24% S.H.N. Financial Investments Ltd. 14 Aug 2025
CYN Cyngn Inc. Common Stock, $0.00001 par value per share 1.4% $3.17M $2.7M 3.73M +583% S.H.N. Financial Investments Ltd. 31 Dec 2024
XPON Expion360 Inc. Common Stock, par value $0.001 0.13% $3.77K 5.38K S.H.N. Financial Investments Ltd. 31 Dec 2024
CETX Cemtrex, Inc. Common Stock, par value $0.001 0.01% $12.30 112 S.H.N. Financial Investments Ltd. 31 Dec 2024
MGOL MGO Global Inc. Common Stock, par value $0.00001 per share 0% $0 -$341K 0 -100% S.H.N. Financial Investments Ltd. 14 Aug 2025
YAAS Youxin Technology Ltd Class A Ordinary Shares, par value $0.0001 per share 0% $0 -$325K 0 -100% S.H.N. Financial Investments Ltd. 14 Nov 2025
HSAI Globavend Holdings Ltd Ordinary Shares, par value $0.001 per share 0% $0 -$54.9M 0 -100% S.H.N. Financial Investments Ltd. 14 Aug 2025
AEON AEON Biopharma, Inc. Class A Common Stock, par value $0.0001 per share 0% $0 -$378K 0 -100% S.H.N. Financial Investments Ltd. 31 Mar 2025
RIME Algorhythm Holdings, Inc. Common Stock, par value $0.01 per share 0% $0 -$102K 0 -100% S.H.N. Financial Investments Ltd. 31 Dec 2024
GNLN Greenlane Holdings, Inc. Class A Common Stock, par value $0.01 per share 0% $0 -$202K 0 -100% S.H.N. Financial Investments Ltd. 31 Mar 2025
NUWE Nuwellis, Inc. Common stock, par value $0.0001 0% $0 0 S.H.N. Financial Investments Ltd. 31 Dec 2024
FMTO Femto Technologies Inc. Common Shares 0% $0 -$8.75K 0 -100% S.H.N. Financial Investments Ltd. 31 Mar 2025
DMN Damon, Inc. Common Stock, $0.001 par value 0% $0 -$163K 0 -100% S.H.N. Financial Investments Ltd. 31 Mar 2025
Blue Hat Interactive Entertainment Technology Ordinary Shares, par value $0.01 per share 0% 0 -100% S.H.N. Financial Investments Ltd. 31 Mar 2025
IXHL Incannex Healthcare Inc. Common Stock 0% 0 -100% S.H.N. Financial Investments Ltd. 31 Mar 2025
ELAB PMGC Holdings Inc. Common Stock, par value $0.0001 per share 0% 0 -100% S.H.N. Financial Investments Ltd. 31 Mar 2025
HEPA Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% 0 -100% S.H.N. Financial Investments Ltd. 14 Aug 2025

Schedules 13D/G Reported by S.H.N. Financial Investments Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.